Parnassus Investments
CVS icon

Parnassus Investments’s CVS Health CVS Stock Holding History

Parnassus Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,372,832
Closed -$622M – 103
2019
Q4 		$622M Buy
8,372,832
+111,538
+1% +$7.83M 2.09% 18
2019
Q3 		$521M Buy
8,261,294
+1,020,904
+14% +$60.5M 1.89% 24
2019
Q2 		$395M Sell
7,240,390
-4,399,039
-38% -$237M 1.49% 30
2019
Q1 		$628M Sell
11,639,429
-2,152,831
-16% -$133M 2.48% 16
2018
Q4 		$904M Sell
13,792,260
-2,675,101
-16% -$200M 3.94% 1
2018
Q3 		$1.3B Sell
16,467,361
-192,140
-1% -$13.7M 4.95% 1
2018
Q2 		$1.07B Buy
16,659,501
+350,872
+2% +$23.1M 4.27% 2
2018
Q1 		$1.01B Buy
16,308,629
+9,095,499
+126% +$653M 4.1% 2
2017
Q4 		$523M Sell
7,213,130
-97,153
-1% -$7.06M 2.05% 16
2017
Q3 		$594M Buy
7,310,283
+26,751
+0.4% +$2.12M 2.44% 11
2017
Q2 		$586M Buy
7,283,532
+1,046,516
+17% +$82.6M 2.47% 14
2017
Q1 		$474M Buy
6,237,016
+175,695
+3% +$14M 2.21% 18
2016
Q4 		$478M Buy
6,061,321
+255,791
+4% +$20.7M 2.36% 17
2016
Q3 		$517M Buy
5,805,530
+1,758,049
+43% +$166M 2.82% 11
2016
Q2 		$388M Buy
4,047,481
+226,519
+6% +$22.6M 2.36% 21
2016
Q1 		$396M Buy
3,820,962
+29,536
+0.8% +$2.87M 2.54% 17
2015
Q4 		$355M Buy
3,791,426
+378,383
+11% +$37.1M 2.38% 17
2015
Q3 		$316M Sell
3,413,043
-188,937
-5% -$19.9M 2.33% 16
2015
Q2 		$378M Sell
3,601,980
-92,107
-2% -$9.41M 2.7% 12
2015
Q1 		$381M Buy
3,694,087
+155,807
+4% +$15.8M 2.73% 13
2014
Q4 		$341M Sell
3,538,280
-81
-0% -$7.14K 2.57% 12
2014
Q3 		$282M Hold
3,538,361
– – 2.41% 13
2014
Q2 		$267M Buy
3,538,361
+374,100
+12% +$28.3M 2.34% 15
2014
Q1 		$237M Sell
3,164,261
-958
-0% -$67.7K 2.29% 12
2013
Q4 		$227M Buy
3,165,219
+11,484
+0.4% +$738K 2.31% 16
2013
Q3 		$179M Buy
3,153,735
+3,735
+0.1% +$223K 2.05% 20
2013
Q2 		$180M Buy
+3,150,000
New +$182M 2.36% 15

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parnassus Investments's CVS Position: Q1 2020 in Review

Parnassus Investments sold out of CVS Health (CVS) in Q1 2020, closing a stake of 8,372,832 shares — an estimated $622M sold.

Parnassus Investments first reported a position in CVS in Q2 2013 and held it in 27 quarters. The position peaked at $1.3B in Q3 2018. 1,816 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

  • Parnassus Investments reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
  • Parnassus Investments sold 8,372,832 CVS Health shares in Q1 2020, an estimated $622M.
  • Parnassus Investments first reported a position in CVS Health in Q2 2013 and held it in 27 quarters.
  • Parnassus Investments's CVS Health position peaked at $1.3B in Q3 2018.
  • 1,816 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Parnassus Investments's 13F filing for Q1 2020, filed 1 May 2020.